Stella v. LVMH Perfumes and Cosmetics USA, Inc.

564 F. Supp. 2d 833, 2008 U.S. Dist. LEXIS 52072, 2008 WL 2669662
CourtDistrict Court, N.D. Illinois
DecidedJuly 8, 2008
Docket07 C 6509
StatusPublished
Cited by15 cases

This text of 564 F. Supp. 2d 833 (Stella v. LVMH Perfumes and Cosmetics USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stella v. LVMH Perfumes and Cosmetics USA, Inc., 564 F. Supp. 2d 833, 2008 U.S. Dist. LEXIS 52072, 2008 WL 2669662 (N.D. Ill. 2008).

Opinion

MEMORANDUM OPINION AND ORDER

ELAINE E. BUCKLO, District Judge.

Defendant LVMH Perfumes and Cosmetics USA, Inc. (“LVMH”) moves to dismiss the complaint brought by plaintiff Pamela Stella, individually and on behalf of all others similarly situated, for failure to state a claim under FED. R. CIV. P. 12(b)(6). For the following reasons, the motion is granted in part.

I.

Defendant is in the business of selling luxury goods, including Hennessy cognac, Dom Perignon champagne, and Christian Dior perfumes and cosmetics. This case concerns Christian Dior’s “Addict Positive Red” lipstick (“lipstick”), which is sold at various retailers throughout the United States. The complaint alleges that on October 11, 2007, the Campaign for Safe Cosmetics (“CFS”) made public a report revealing that the LVMH’s lipstick products contain dangerous levels of lead. According to plaintiff, the tests conducted by the CFS revealed that the lipstick contained lead in the amount of .21 parts per million (“ppm”), when the U.S. Food and Drug Administration has established a limit of .1 ppm for levels of lead in candy.

Plaintiff alleges she purchased the lipstick at a Nordstrom department store in June 2007 for personal use. As a result, she claims to have been exposed to lead, which is contained in the lipstick. According to the complaint, LVMH’s marketing of the lipstick “affirmatively and impliedly” assured consumers that the product was safe for use.

The complaint alleges claims under the Illinois Consumer Fraud and Deceptive Business Practices Act (“ICFA”), 815 ILCS 505/1, et seq. (2007) (count I); breach of implied warranty pursuant to the Uniform Commercial Code (“UCC”) (count II); breach of implied warranty pursuant to the Magnuson-Moss Warranty Act (“MMWA”) (count III); strict liability (count IV); and negligence per se (count V); unjust enrichment (count VI); and injunctive relief (count VII).

II.

In assessing defendant’s motion to dismiss under Fed. R. Civ. P. 12(b)(6), I must view the allegations in the light most favorable to the plaintiff and accept all well-pleaded facts in the complaint as true. McMillan v. Collection Prof'ls, 455 F.3d 754, 758 (7th Cir.2006) (citation omitted). “Factual allegations must be enough to raise a right to relief above the speculative level.” Bell Atl. Corp. v. Twombly, 550 U.S. -, 127 S.Ct. 1955, 1965, 167 L.Ed.2d 929 (May 21, 2007); E.E. O.C. v. Concentra Health Servs., Inc., 496 F.3d 773, 776-77 (7th Cir.2007). Moreover, under Rule 9(b), allegations of fraud are subject to heightened pleading requirements. Fed. R. Civ. P. 9(b). Fraud must be pled with particularity and the complaint must allege the “who, what, when, where, and how” of the fraud. DiLeo v. Ernst & Young, 901 F.2d 624, 627 (7th Cir.1990).

III.

A. Count I: ICFA

The complaint alleges defendant violated the ICFA. To state a claim under the ICFA plaintiff must allege “(1) a deceptive act or practice by the defendant, *836 (2)the defendant’s intent that the plaintiff rely on the deception, (3) the occurrence of the deception in the course of conduct involving trade or commerce, and (4) actual damage to the plaintiff (5) proximately caused by the deception.” Avery v. State Farm Mut. Auto. Ins. Co., 216 Ill.2d 100, 180, 296 Ill.Dec. 448, 835 N.E.2d 801, 850 (111.2005) (citation omitted). In addition, claims under the ICFA must be pled with particularity. See Villasenor v. Am. Signature Inc., No. 06 C 5493, 2008 WL 904888, at *2 (Mar. 31, 2008) (Kendall, J.) (citations omitted).

When the allegations are taken in the best light to plaintiff, they state a claim under the ICFA and provide defendant with adequate notice of the claim. The complaint specifically alleges defendant failed to include lead in its ingredient list for the lipstick and that she would not have purchased the lipstick had she known she would have been exposed to the lead contained in the product. Plaintiff alleges that as the manufacturer of the lipstick, defendant knew or should have known that lead was an ingredient and that it failed to disclose this fact to consumers in listing the product’s ingredients. Plaintiff seeks to recover actual damages in the form of pecuniary damages (the cost of the lipstick) and medical monitoring. Actual damages include pecuniary losses. Id. at *4. And in the absence of guidance from the Illinois Supreme Court on the propriety of medical monitoring claims under Illinois law, I find persuasive the federal case law finding such a claim cognizable under Illinois law. See, e.g., Carey v. Kerr-McGee Chemical Corp., 999 F.Supp. 1109, 1118-19 (N.D.Ill.1998) (Gettleman, J.). 1 Finally, plaintiff has alleged that her reliance on defendant’s omission caused her to buy the lipstick and become exposed to lead. This sufficiently alleges proximate cause. Accordingly, the motion to dismiss count I is denied.

B. Counts II and III: Breach of Implied Warranty Pursuant to the U.C.C. and the MMWA.

Defendant first argues that plaintiff has failed to plead the goods are not “merchantable” under Illinois law. 810 ILCS § 5/2-314. For goods to be considered “merchantable,” they must conform to a set of standards which includes being “fit for the ordinary purposes for which such goods are used.” 810 ILCS 5/2-314(c). Although defendant concedes the complaint plainly alleges there are dangerous levels of lead in the lipstick, it still argues this does not sufficiently provide the lipstick was not fit for its ordinary purpose. This argument has no merit under federal pleading standards. See Concentra Health Servs., 496 F.3d at 776-77, 779-80. Both parties agree the ordinary purpose of lipstick is to color its user’s lips in a reasonably safe manner. The complaint plainly alleges the lipstick was not safe. Accordingly, the motion to dismiss on this ground is denied.

Defendant also moves to dismiss counts II and III on the ground that plaintiffs failed to provide pre-suit notice as required by the UCC and the MMWA. Under the UCC, a plaintiff-buyer pursuing a breach of warranty claim must give the seller notice of the claimed breach or be barred from recovery. U.C.C. § 2-607; *837 810 ILCS 5/2-607 (3)(A). This notice requirement is intended to encourage pre-suit settlement negotiations, see U.C.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Velez v. RM Acquisition, LLC
N.D. Illinois, 2023
Van Zeeland v. Rand McNally
N.D. Illinois, 2021
DeBernardis v. NBTY, Inc.
N.D. Illinois, 2018
Nancy Kuns v. Ford Motor Company
543 F. App'x 572 (Sixth Circuit, 2013)
Reid v. Unilever United States, Inc.
964 F. Supp. 2d 893 (N.D. Illinois, 2013)
Keegan v. American Honda Motor Co.
838 F. Supp. 2d 929 (C.D. California, 2012)
Frye v. L'OREAL USA, INC.
583 F. Supp. 2d 954 (N.D. Illinois, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
564 F. Supp. 2d 833, 2008 U.S. Dist. LEXIS 52072, 2008 WL 2669662, Counsel Stack Legal Research, https://law.counselstack.com/opinion/stella-v-lvmh-perfumes-and-cosmetics-usa-inc-ilnd-2008.